Ryota Tanaka
- Oncology top 2%
- Immunology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Epidemiology
- Co-authors
- Naoko OkiyamaYasuhiro FujisawaManabu FujimotoHiroshi MaruyamaYoshiyuki NakamuraYasuhiro NakamuraRei WatanabeYosuke Ishitsuka
- Topics
- Cancer Immunotherapy and Biomarkers (21 papers)Immunotherapy and Immune Responses (17 papers)Melanoma and MAPK Pathways (9 papers)
- Cited by
- OncologyImmunologyDermatology
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Ryota Tanaka
67 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 84
- Oncology 1.0k
- Immunology 457
- Molecular Biology 311
- Pulmonary and Respiratory Medicine 247
- Epidemiology 225
Countries citing papers authored by Ryota Tanaka
This map shows the geographic impact of Ryota Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryota Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryota Tanaka more than expected).
Fields of papers citing papers by Ryota Tanaka
This network shows the impact of papers produced by Ryota Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryota Tanaka. The network helps show where Ryota Tanaka may publish in the future.
Co-authorship network of co-authors of Ryota Tanaka
This figure shows the co-authorship network connecting the top 25 collaborators of Ryota Tanaka. A scholar is included among the top collaborators of Ryota Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryota Tanaka. Ryota Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 13 | |
| 4 | 0 | |
| 5 | 12 | |
| 6 | 25 | |
| 7 | 3 | |
| 8 | 31 | |
| 9 | 11 | |
| 10 | 4 | |
| 11 | 23 | |
| 12 | 5 | |
| 13 | 40 | |
| 14 | 8 | |
| 15 | 33 | |
| 16 | 100 | |
| 17 | 4 | |
| 18 | 35 | |
| 19 | 5 | |
| 20 | 34 |
About Ryota Tanaka
Ryota Tanaka is a scholar working on Oncology, Dermatology and Immunology, having authored 71 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (21 papers), Immunotherapy and Immune Responses (17 papers) and Melanoma and MAPK Pathways (9 papers). The work is most often cited by research in Oncology (1.0k citations), Immunology (457 citations) and Dermatology (105 citations). Ryota Tanaka has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Naoko Okiyama, Yasuhiro Fujisawa, Manabu Fujimoto, Hiroshi Maruyama, Yoshiyuki Nakamura, Yasuhiro Nakamura, Rei Watanabe, Yosuke Ishitsuka, Yukiko Teramoto and Akifumi Yamamoto. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.